Geoffrey B. Varty

3.9k citations
65 papers · 3.2k · h-index 37

Impact in

Papers in

  • Cellular and Molecular Neuroscience 40
    • Neuropeptides and Animal Physiology 20
    • Neurotransmitter Receptor Influence on Behavior 15
    • Neuroscience and Neuropharmacology Research 14
  • Molecular Biology 36
    • Receptor Mechanisms and Signaling 28
    • Pharmacological Receptor Mechanisms and Effects 8
Co-authors
Guy A. Higgins (14 shared papers)Mark A. Geyer (9 shared papers)Mary Cohen-Williams (13 shared papers)Robert A. Hodgson (14 shared papers)David Braff (2 shared papers)Jean E. Lachowicz (12 shared papers)Eric M. Parker (11 shared papers)John C. Hunter (7 shared papers)
Journals
Bioorganic & Medicinal Chemistry Letters (12 papers)European Journal of Pharmacology (7 papers)Psychopharmacology (7 papers)Pharmacology Biochemistry and Behavior (6 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)
Partner nations
United StatesUnited KingdomFrance

In The Last Decade

Geoffrey B. Varty

64 papers receiving 3.1k citations

Peers

Geoffrey B. Varty
Comparison fields: 5 of 109
  • Behavioral Neuroscience 606
  • Cellular and Molecular Neuroscience 1.8k
  • Biological Psychiatry 222
  • Physiology 222
  • Endocrine and Autonomic Systems 226
Replace Ian A. Paul with:
Ian A. Paul United States
Ellen M. Unterwald United States
Nicola Simola Italy
Habibeh Khoshbouei United States
Ian Kitchen United Kingdom
Claudia Schmauss United States
Ryan K. Bachtell United States
Ezio Carboni Italy
M.N. Perkins United Kingdom
Javier González‐Maeso United States
Geoffrey B. Varty relative to Ian A. Paul United States Ian A. Paul's profile →
Citations per field
00.5×1.5×1.9×
Ian A. Paul · 1×
Citations per year

Countries citing papers authored by Geoffrey B. Varty

Since Specialization
Citations

This map shows the geographic impact of Geoffrey B. Varty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey B. Varty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey B. Varty more than expected).

Fields of papers citing papers by Geoffrey B. Varty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey B. Varty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey B. Varty. The network helps show where Geoffrey B. Varty may publish in the future.

Co-authors

The 25 scholars most cited alongside Geoffrey B. Varty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Geoffrey B. Varty Line = papers co-authored together Geoffrey B. Varty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
Psychopharmacology ·Geoffrey B. Varty, Guy A. Higgins
1995204
2
Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity
Biological Psychiatry ·Geoffrey B. Varty, Martin P. Paulus, David Braff, Mark A. Geyer
2000174
3
M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats
Neuropsychopharmacology ·Geoffrey B. Varty
1999163
4
The Dopamine D2, but not D3or D4, Receptor Subtype is Essential for the Disruption of Prepulse Inhibition Produced by Amphetamine in Mice
Journal of Neuroscience ·Rebecca J. Ralph, Geoffrey B. Varty, Michele A. Kelly, Yan-Min Wang, Marc G. Caron, Marcelo Rubinstein, David K. Grandy, Malcolm J. Low, Mark A. Geyer
1999143
5
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles
Psychopharmacology ·Geoffrey B. Varty, Mariagrazia Grilli, A Forlani, Silva Fredduzzi, Michael E. Grzelak, Donald H. Guthrie, Robert A. Hodgson, Sherry Lu, Elisa Nicolussi, Annamarie J. Pond, Eric M. Parker, John C. Hunter, Guy A. Higgins, Angelo Reggiani, Rosalia Bertorelli
2005140
6
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
Journal of Pharmacology and Experimental Therapeutics ·Robert A. Hodgson, Rosalia Bertorelli, Geoffrey B. Varty, Jean E. Lachowicz, A Forlani, Silva Fredduzzi, Mary Cohen-Williams, Guy A. Higgins, Francesco Impagnatiello, Elisa Nicolussi, Leonard E. Parra, Carolyn Foster, Ying Zhai, B Neustadt, Andrew W. Stamford, Eric M. Parker, Angelo Reggiani, John C. Hunter
2009128
7
Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-{2-methoxy-1(R)-4-(trifluoromethyl)phenyl}ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist
Journal of Medicinal Chemistry ·Jayaram R. Tagat, Stuart W. McCombie, Dennis V. Nazareno, Marc Labroli, Yushi Xiao, Ruo W. Steensma, Julie Strizki, Bahige M. Baroudy, Kathleen Cox, Jean E. Lachowicz, Geoffrey B. Varty, Robert W. Watkins
2004112
8
The Gerbil Elevated Plus-maze II Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists
Neuropsychopharmacology ·Geoffrey B. Varty
200299
9
Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats.
Behavioral Neuroscience ·Geoffrey B. Varty, Mark A. Geyer
199891
10
Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats.
Behavioral Neuroscience ·Geoffrey B. Varty, Mark A. Geyer
199883
11
Reduced synaptophysin immunoreactivity in the dentate gyrus of prepulse inhibition-impaired isolation-reared rats
Brain Research ·Geoffrey B. Varty, C.A. Marsden, Guy A. Higgins
199982
12
Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
Experimental Neurology ·Robert A. Hodgson, Paul J. Bédard, Geoffrey B. Varty, Tatiana M. Kazdoba, Thérèse Di Paolo, Michael E. Grzelak, Annamarie J. Pond, Abdallah Hadj-Tahar, Nancy Bélanger, Laurent Grégoire, Aurelie Dare, Bernard R. Neustadt, Andrew W. Stamford, John C. Hunter
201078
13
Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species
Psychopharmacology ·Geoffrey B. Varty, Lynn A. Hyde, Robert A. Hodgson, Steve Lu, Martha F. McCool, Tatiana M. Kazdoba, Robert A. Del Vecchio, Donald H. Guthrie, Annamarie J. Pond, M. E. Grzelak, Xiaoying Xu, Walter A. Korfmacher, Deen Tulshian, Eric M. Parker, Guy A. Higgins
200574
14
Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils
Neuropharmacology ·Ruth A. Duffy, Joseph A. Hedrick, G. Randolph, Cynthia A. Morgan, Mary Cohen-Williams, Galya Vassileva, Jean E. Lachowicz, Maureen Laverty, Michael E. Maguire, Limei Shan, Eric L. Gustafson, Geoffrey B. Varty
200371
15
The Gerbil Elevated Plus-Maze I Behavioral Characterization and Pharmacological Validation
Neuropsychopharmacology ·Geoffrey B. Varty
200270
16
Differences between three rat strains in sensitivity to prepulse inhibition of an acoustic startle response: influence of apomorphine and phencyclidine pretreatment
Journal of Psychopharmacology ·Geoffrey B. Varty, Guy A. Higgins
199470
17
Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression
Pharmacology Biochemistry and Behavior ·Robert A. Hodgson, Guy A. Higgins, Donald H. Guthrie, Steve Lu, Annamarie J. Pond, Deborra Mullins, M. Guzzi, Eric M. Parker, Geoffrey B. Varty
200768
18
Melanin-concentrating hormone-1 receptor antagonism decreases feeding by reducing meal size
European Journal of Pharmacology ·Timothy J. Kowalski, Constance Farley, Mary Cohen-Williams, Geoffrey B. Varty, Brian D. Spar
200468
19
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat
Psychopharmacology ·Mark D. Black, Geoffrey B. Varty, Michal Arad, Segev Barak, Amaya De Levie, Denis Boulay, Philippe Pichat, Guy Griebel, Ina Weiner
200868
20
The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)
Journal of Pharmacology and Experimental Therapeutics ·Geoffrey B. Varty, Sherry Lu, Cynthia A. Morgan, Mary Cohen-Williams, Robert A. Hodgson, April Smith‐Torhan, Hongtao Zhang, Ahmad Fawzi, Michael P. Graziano, Ginny D. Ho, Julius J. Matasi, Deen Tulshian, Vicki L. Coffin, Galen Carey
200867

About Geoffrey B. Varty

Geoffrey B. Varty is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Behavioral Neuroscience, Social Psychology and Physiology, having authored 65 papers that have together received 3.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (28 papers), Neuropeptides and Animal Physiology (20 papers), Neurotransmitter Receptor Influence on Behavior (15 papers), Neuroscience and Neuropharmacology Research (14 papers), Stress Responses and Cortisol (13 papers), Neuroendocrine regulation and behavior (12 papers), Adenosine and Purinergic Signaling (8 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). The work is most often cited by research in Behavioral Neuroscience (606 citations), Cellular and Molecular Neuroscience (1.8k citations), Biological Psychiatry (222 citations), Physiology (222 citations) and Endocrine and Autonomic Systems (226 citations). Geoffrey B. Varty has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Guy A. Higgins, Mark A. Geyer, Mary Cohen-Williams, Robert A. Hodgson, David Braff, Jean E. Lachowicz, Eric M. Parker, John C. Hunter, Martin P. Paulus and Annamarie J. Pond. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, European Journal of Pharmacology, Psychopharmacology, Pharmacology Biochemistry and Behavior and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian A. PaulBreakdown of academic impact, for papers by Ellen M. UnterwaldBreakdown of academic impact, for papers by Nicola SimolaBreakdown of academic impact, for papers by Habibeh KhoshboueiBreakdown of academic impact, for papers by Ian KitchenBreakdown of academic impact, for papers by Claudia SchmaussBreakdown of academic impact, for papers by Ryan K. BachtellBreakdown of academic impact, for papers by Ezio CarboniBreakdown of academic impact, for papers by M.N. PerkinsBreakdown of academic impact, for papers by Javier González‐Maeso